Table 5 Relationship between LDL-C/HDL-C ratio and AF in different sensitivity analyses.

From: Inverse relationship between LDL-C/HDL-C ratio and atrial fibrillation in chronic kidney disease patients

Exposure

Model I (OR, 95%CI, P)

Model II (OR, 95%CI, P)

Model III (OR, 95%CI, P)

Model IV (OR, 95%CI, P)

LDL-C/HDL-C ratio

0.392 (0.251, 0.613) 0.00004

0.252 (0.144, 0.442) < 0.00001

0.407 (0.256, 0.647) 0.00015

0.424 (0.271, 0.661) 0.00015

LDL-C/HDL-C ratio (quartile)

 Q1

Ref

Ref

Ref

Ref

 Q2

0.803 (0.563, 1.147) 0.22809

0.746 (0.498, 1.117) 0.15427

0.812 (0.562, 1.173) 0.26624

0.768 (0.533, 1.108) 0.15776

 Q3

0.641 (0.437, 0.940) 0.02285

0.540 (0.346, 0.841) 0.00642

0.624 (0.418, 0.932) 0.02115

0.689 (0.471, 1.007) 0.05429

 Q4

0.425 (0.279, 0.646) 0.00006

0.303 (0.178, 0.516) 0.00001

0.444 (0.287, 0.686) 0.00025

0.449 (0.296, 0.682) 0.00017

P for trend

0.00003

< 0.00001

0.00009

0.00015

  1. Model I was sensitivity analysis in participants without the patients with the history of PAD. We adjusted age, gender, WC, education, history of alcohol intake, smoking, DM, hypertension, MI, DBP, SBP, CRP, proteinuria, TG, eGFR.
  2. Model II was sensitivity analysis in participants without the patients with the history of hypertension. We adjusted age, gender, WC, education, history of alcohol intake, smoking, DM, MI, PAD, DBP, SBP, CRP, proteinuria, TG, eGFR.
  3. Model III was sensitivity analysis in participants without the patients with the history of DM. We adjusted age, gender, WC, education, history of alcohol intake, smoking, hypertension, MI, PAD, DBP, SBP, CRP, proteinuria, TG, eGFR.
  4. Model IV was sensitivity analysis in participants without the patients with the history of MI. We adjusted age, gender, WC, education, history of alcohol intake, smoking, DM, hypertension, PAD, DBP, SBP, CRP, proteinuria, TG, eGFR.
  5. OR odds ratios; CI confidence, Ref reference; LDL-C/HDL-C ratio low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio.